Moexiprilat - CISMeF

Preferred Label : Moexiprilat;

NCIt definition : A non-sulfhydryl angiotensin converting enzyme (ACE) inhibitor with antihypertensive activity. Moexiprilat competitively inhibits ACE, thereby blocking the conversion of angiotensin I to angiotensin II. This prevents the actions of the potent vasoconstrictor angiotensin II and leads to vasodilatation. This agent also prevents angiotensin II-induced aldosterone secretion by the adrenal cortex, thereby promoting diuresis and natriuresis.;

UNII : H3753190JS;

InChIKey : CMPAGYDKASJORH-YSSFQJQWSA-N;

CAS number : 103775-14-0;

Molecule name : RS 10029;

Chemical formula : C25H30N2O7;

Details

Origin ID

C66175;

UMLS CUI

C0209137;

Currated CISMeF NLP mapping
- moexiprilat [MeSH concept]
- moexiprilat [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- moexiprilat [MeSH Supplementary Concept]
- moexiprilat [MeSH concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
has_salt_form
- Moexiprilat Hydrochloride [NCIt concept]
is_free_acid_or_base_form_of
- Moexiprilat Hydrochloride [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients